Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
protein
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:chemicalFormula |
peptide
|
| gptkbp:clinicalTrials |
Phase 3
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| https://www.w3.org/2000/01/rdf-schema#label |
Somatrogon
|
| gptkbp:issuedBy |
subcutaneous injection
|
| gptkbp:marketedAs |
the brand name Zhyprexa
|
| gptkbp:sideEffect |
fatigue
headache muscle pain nausea injection site reactions |
| gptkbp:targets |
pediatric patients
|
| gptkbp:triggerType |
growth hormone receptor agonist
|
| gptkbp:usedFor |
growth hormone deficiency
|